Pancreatic Insufficiency Completed Phase 3 Trials for Pancrelipase (DB00085)

Also known as: Pancreatic failure / Pancreatic insufficiency (disorder) / Insufficiency pancreatic / Exocrine pancreatic insufficiency / Pancreatic exocrine insufficiency / Exocrine pancreatic insufficiency (disorder)

IndicationStatusPhase
DBCOND0031191 (Pancreatic Insufficiency)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00880100Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)Treatment
NCT00705978Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic PancreatitisTreatment
NCT00513682Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)Treatment
NCT00432861Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic FibrosisTreatment